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Abstract
Background: Arginine vasopressin has been shown to affect social and emotional behaviors, which is mediated by
the arginine vasopressin receptor (AVPR1A). Genetic polymorphisms in the AVPR1A promoter region have been
identified to be associated with susceptibility to social deficits in autism spectrum disorder (ASD). We hypothesize
that alleles of polymorphisms in the promoter region of AVPR1A may differentially interact with certain
transcriptional factors, which in turn affect quantitative traits, such as sociality, in children with autism.
Methods: We performed an association study between ASD and polymorphisms in the AVPR1A promoter region in
the Korean population using a family-based association test (FBAT). We evaluated the correlation between genotypes
and the quantitative traits that are related to sociality in children with autism. We also performed a promoter assay in
T98G cells and evaluated the binding affinities of transcription factors to alleles of rs7294536.
Results: The polymorphisms—RS1, RS3, rs7294536, and rs10877969—were analyzed. Under the dominant model,
RS1–310, the shorter allele, was preferentially transmitted. The FBAT showed that the rs7294536 A allele was also
preferentially transmitted in an additive and dominant model under the bi-allelic mode. When quantitative traits were
used in the FBAT, rs7294536 and rs10877969 were statistically significant in all genotype models and modes. Luciferase
and electrophoretic mobility-shift assays suggest that the rs7294536 A/G allele results in a Nf-κB binding site that
exhibits differential binding affinities depending on the allele.
Conclusion: These results demonstrate that polymorphisms in the AVPR1A promoter region might be involved in
pathophysiology of ASD and in functional regulation of the expression of AVPR1A.
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Background
Autism spectrum disorder (ASD) is complex neuropsychi-
atric developmental disorders characterized by social
communication impairments and restricted interests [1]. In
spite of heterogeneous etiology, molecular genetic studies
for ASD have identified susceptible candidate genes, such
as those involved in neurobiological pathways, chromatin
remodeling, protein translation, actin dynamics, and synap-
tic functions [2, 3].
Arginine vasopressin receptor 1A (AVPR1A), a receptor
for arginine vasopressin (AVP), is coupled to the Gαq/11
G-protein coupled receptor and is activated by binding
AVP via phospholipase C. The subsequent activation of
protein kinase C helps mediate neuronal development,
memory formation, synaptic plasticity, and neuronal
survival [4, 5]. Animal and human physiobiological studies
have also demonstrated that social behavior is affected by
AVPR1A [6–8]. Furthermore, AVP and AVPR1A have
been shown to play crucial roles in the pathophysiology of
psychiatric disorders such as anxiety, depression, and
post-traumatic stress disorder in rodents [9, 10]. AVPR1A
signaling has also been shown to be involved in human
social and emotional behavior as demonstrated in a study
using the AVPR1A antagonist SRX246 [9]. Furthermore,
administration of AVP via a nasal spray has been shown
to improve social recognition of emotionally balanced
faces in humans [11]. The variations in the gene structure
of AVPR1A mostly occur in the form of genetic polymor-
phisms, which have been proposed to underlie inter- and
intra-specific differences in expression levels [12, 13] and
spatial expression patterns in the brain. The promoter
region of AVPR1A includes a number of highly
polymorphic microsatellites, such as RS1 and RS3 [14].
Furthermore, genetic variations in the promoter region of
AVPR1A have also been associated with risks for autism,
in which social deficits are the major symptoms, as well as
autism phenotypes in nonclinical populations [15–19].
Previous association studies from various populations
have been focused on examining association of RS 1, RS3,
and a few SNPs resulting in inconsistent results [20]. For
instance, Tansey et al. [13] demonstrated that the shorter
alleles of RS1 had weaker associations with autism in the
Irish population. One recent study reported association of
RS1 and RS3 with repetitive behaviors, but not diagnosis
of ASD [21]. Both RS1 and RS3 showed differences in
relative promoter activity as measured in the human
neuroblastoma cell line, SH-SY5Y, with the shorter repeat
alleles of RS1 and RS3 exhibiting decreased relative pro-
moter activity [13]. Meyer-Lindenberg et al. [22] also
reported abnormal amygdala signaling is involved in the
pathophysiology of autism. Our previous studies have also
shown statistically significant associations between ASD
and the shorter alleles of RS1 and RS3, which have been
reported to be over-transmitted as risk alleles in other
populations [23]. We have also previously reported a
statistically significant association of ASD with the single
nucleotide polymorphisms (SNPs) rs10877969 and
rs7294536 in the promoter region of AVPR1A [24].
Overall, the first objective of this study was to validate
our previous association study between ASD and the poly-
morphisms RS1, RS3, rs7294536, and rs10877969 in
AVPR1A with samples from independent cohorts from
our previous studies. We analyzed quantitative correlation
between genotypes and quantitative traits in probands
with ASD. For these analyses, we selected quantitative
traits which reflect sociality directly among various inven-
tories used for phenotypic measures of the subjects. The
second is to determine the effects of the polymorphisms
on the expression level of AVPR1A. Therefore, we used
luciferase assays to ascertain the functional sequence
polymorphisms in the promoter region in T98G cells. We
also use electrophoretic mobility-shift assay (EMSA) to
evaluate how the promoter polymorphisms affect nuclear
protein-binding affinities. For this, we analyzed Korean
family trios composed of subjects with ASD and their
biological parents, diagnosed by pervasive developmental
disorder based on DSM-IV-TR diagnostic criteria.
Methods
Subjects
Probands and their biological parents were ascertained for
ASD based on the DSM-IV-TR diagnostic criteria. To
confirm the ASD diagnosis, the parents or caregivers were
interviewed with the Korean version of Autism Diagnostic
Interview-Revised (K-ADI-R) [25], and the probands were
assessed with the Korean version of the Autism Diagnostic
Observation Schedule (K-ADOS) [26]. We assessed “social
ability and other behavioral symptoms of the probands by
using the Social Communication Questionnaires (SCQ)
[27], Asperger Syndrome Diagnostic Scale (ASDS) [28],
Social Responsiveness Scale (SRS) [29], and Korean Child
Behavior Checklist (K-CBCL) [30].” The Korean versions
of the Social Maturity Scale (K-SMS) [31], Vineland Adap-
tive Behavior Sales-Interview (VABS) [32], and of Korean
Educational Development Institute-Wechsler Intelligence
Scale for Children-Revised (KEDI-WISC-R) [33] were
used for examining adaptive functioning and intelligence.
We only included subjects showing clear phenotype of
ASD by clinical best estimate diagnosis by two board cer-
tified psychiatrists, based on those diagnostic instruments
and measures. For diagnostic validity and reliability, the
age of the probands was limited to 36 months or older.
We did not put any limitation for gender. For the
probands suspected to have known genetic or neurological
anomalies, including Down syndrome, fragile X syndrome,
tuberous sclerosis, and karyotyping and neurological
examinations were performed in the screening stage to
identify and exclude those subjects from further analyses.
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The subjects either parent has declared he or she has
non-Korean ethnicity were excluded from enrolment.
Written informed consent was obtained from the
biological parents or caregivers. This study was approved
by Seoul National University Bundang Hospital Institu-
tional Review Board (IRB_B-1406/253–001).
Genotyping
Blood samples in EDTA tubes were kept at −70 °C before
use. Genomic DNA was extracted from blood using
QIAamp® DNA Blood kit (Qiagen, Seoul, Korea).
Amplifications of the RS3 [Complex (CT)4-TT-(CT)8-
(GT)24] and RS1 [(GATA)n tetranucleotide repeats] were
performed according to method reported by Yang et al.
(2010) (Additional file 1: Table S1 shows this in more
detail). The size of the labeled PCR products was deter-
mined by capillary electrophoresis on an ABI 3100 sequen-
cer using Gene Scan Software 2.02 (ABI, Foster city, CA,
USA). Five alleles of RS3 were found in all participants in
multiples of 2 bp, and there were six alleles of RS1 with
multiples of 4 bp.
Two SNPs, rs7294536 and rs10877969, were genotyped
using sets of primers and probes (BMS, Seoul, Korea) (Add-
itional file 1: Table S1 shows this in more detail). PCRs were
performed with Real-time Master Mix (Toyobo, Osaka,
Japan) following proper reaction conditions on the real-
time PCR machine (BMS, Seoul, Korea). The genotyped
data was collected and the Mendelian inheritance errors for
each individual polymorphism were checked by PedCheck
(v.1.1) to verify the data quality and to identify any genotyp-
ing error. Detail procedure was descripted in Additional file
1: Supplementary Materials and Methods.
Luciferase assay
We used Tfsitescan (http://www.ifti.org/) to predict
rs7294536 variants present within the Nf-κB consensus se-
quence (5′-GGGRNNYYCC-3′). A 1641 bp fragment
encompassing −108 to −1749 bp from of the 5′ regulatory
region of AVPR1A was amplified via PCR using human
DNA (Additional file 1: Table S1 shows this in more detail).
The primers used for cloning AVPR1A contained KpnI and
BglII linkers. The PCR products were first digested by KpnI
and BglII and then were cloned into the multiple cloning
site of the pGL3 reporter vector (Promega, Madison,
WI, USA). The rs7294536 A/G (−1502 bp) and
rs10877969 A/G (−649 bp) variants were generated
using the QuickChange® Site-Directed Mutagenesis Kit
(Stratagene, LA Jolla, CA, USA) with each primer set
(Additional file 1: Table S1 shows this in more detail).
For all four haplotype constructs, the pA-A construct was
subsequently used as a template to generate additional pos-
sible haplotype constructs (i.e., pA-A, pA-G, pG-A, and
pG-G). The pGL3-SV40-AVPR1A construct (encompassing
−108 to −1749 bp from the 5′ regulatory region of
AVPR1A), pRLCMV-renilla, pCMV-p65, and pGL3-basic
vectors were used to transfect T98G cells, which is a hu-
man glioblastoma multiforme cell line, using FuGENE HD
(Roche, Mannheim, Germany). Cell lysates were assessed
using the Dual-Glo Luciferase Assay System (Promega,
Madison, WI, USA) in a Lumat LB 9507 luminometer (EG
&G Berthhold, Bad Wildbad, Germany). Further details are
described in the Additional file 1: Supplementary Materials
and Methods.
EMSA and western blotting
EMSAs were used examine for any quantitative differences
in the binding affinity of Nf-κB sub-family proteins to the A
or G allele of rs7294536. A nuclear extract was prepared
from transfected T98G cells that were either unstimulated
or stimulated with 30 ng/mL TNF-α for 15, 30, and
180 min. Unlabeled double-stranded probes were annealed
with equimolar concentrations of sense and antisense
single-stranded probes. Radiolabeled probes were labeled
with [α-32P] dCTP at the 2-base overhang (GG) on the
5′-end via end labeling with a Klenow fragment and then
purified through a Sephadex G50 column. During the pre-
incubation, the binding reaction was performed with the
prepared nuclear extract and unlabeled probes in the reac-
tion buffer at room temperature. Next, p50/p65 antibodies
were added for the EMSA. Thereafter, radiolabeled probe
(1 ng, 1 × 105 cpm) was added to the reaction mixture and
then incubated for 10 min at room temperature. The reac-
tion mixtures were fractionated on a non-denaturing 6%
polyacrylamide gel at 200 v for 2 h. The gel was transferred
to 3MM paper, dried, and then was visualized by exposing
it to X-ray film. For the EMSA, 10 μg of the nuclear
proteins were denatured and separated on a 4–20% SDS-
polyacrylamide gel (Invitrogen, Medison, WI, USA). The
fractionated proteins were then transferred to a nylon mem-
brane (Millipore, Bedford, MA, USA), and a western blot
was performed with antibodies against rabbit p50 and p65
(Santa Cruz Biotechnology, Santa Cruz CA, USA). Further
details are described in the Additional file 1: Supplementary
Materials and Methods.
Statistical analysis
To assess each individual polymorphism and haplotype,
the transmission disequilibrium test (TDT) using the
family-based association test (FBAT) program package
(http://www.biostat.harvard.edu/fbat/fbat.htm) under avail-
able modes and models was used. The haplotype family-
based association test (HBAT) from the FBAT program
package was used to analyze associations between ASD and
the haplotypes and ASD with a minimum frequency of 5%.
A permutation test of 100,000 cycles was performed using
the Monte Carlo option to determine the statistical power
of HBAT. In addition, the D′ value between the microsatel-
lites and SNPs was estimated with the FBAT program
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package. Statistical significance was considered at p < 0.05
for the TDT haplotype analysis. In addition to the basic
TDT and HBAT, we measured multiple quantitative traits
using the FBAT program. Quantitative traits include
the total score of the ADI-R diagnostic algorithm,
SCQ (lifetime), and subdomain scores of ASDS, SRS,
and K-CBCL (social problems). All of the p values from
the FBAT in our study were subject to Bonferroni correc-
tion to account for multiple testing.
The statistical analyses for luciferase assay were
conducted using a Kruskal-Wallis test, followed by
Dunn’s post hoc test or Mann-Whitney U test. Statistical
significance was considered at p < 0.05. The relative
luciferase units (RLUs) of the constructs were compared
via analysis of variance (ANOVA) or unpaired Student’s
t tests (SPSS. ver.15.0, Chicago, IL, USA).
Results
Subjects
A total of 212 families composed of affected children
(n = 212), as well as their biological mothers (n = 212)
and fathers (n = 209) were analyzed. The mean age of
proband was 97.72 ± 56.42 months old (average ± stand-
ard deviation). Of the probands, 84.44% were males,
87.3% had autistic disorder, 11.3% had pervasive devel-
opmental disorder not otherwise specified (PDD-NOS),
and 1.4% had Asperger’s syndrome as defined by the
DSM-IV-TR diagnostic criteria. Clinical data of the
probands for sociality traits are summarized in
Additional file 1: Table S2.
Genetic association study of the RS1 and RS3
microsatellite polymorphisms
No associations were observed between RS3 and ASD in
the present replication sample set, though a significant as-
sociation was observed in our previous analyses [23]. The
shot allele, RS1–310, was preferentially transmitted in the
dominant model under the allelic mode (Z = 2.302;
p = 0.021) (Table 1).
Genetic association study of single nucleotide
polymorphisms
The FBAT showed that the rs10877969 A allele was sig-
nificantly transmitted in all models and modes
(Z = 4.796; p < 0.001). The rs7294536 A allele also
showed significant transmission in the additive
(Z = 2.062; p = 0.039) and dominant (Z = 2.043;
p = 0.041) models in the bi-allelic mode. These findings
were consistent with our previous report regarding the
transmission of AVPR1A SNPs in ASD (Table 1).
Haplotype analyses
Haplotypes were selected from different combinations of
the four polymorphisms (RS1, RS3, rs7294536, and
rs10877969) using a sliding window approach (frequency
< 0.05). A significant association was found in two hap-
lotypes of rs7294536/rs10877969, A/A (p < 0.001) and
A/G (p < 0.001), under the bi-allelic mode. The RS1/
rs10877969 (310-A, p = 0.011) and rs7294536/RS1/
rs10877969 (A-310-A, p = 0.012) haplotype combina-
tions were significantly associated with ASD. However,
there were no statistically significant associations be-
tween any RS1/RS3 haplotype combinations in this study
(Table 2).
Quantitative association of the markers
The FBAT analysis showed significant association be-
tween the SNPs (rs7294536 and rs10877969) and mul-
tiple quantitative traits related to sociality and social
communication, including total scores of SCQ and SRS,
social trait score of ASDS, and subdomain scores of the
“qualitative abnormality in reciprocal social interaction”
domain of ADI-R (p = 0.03 to < 0.001). For rs10877969,
the FBAT analysis for quantitative traits was statistical
significant in all models and modes. Strongly significant
results (p < 0.001) were observed for analyses of ASDS
social, SRS total, social problems in K-CBCL social prob-
lems, ADIR-A1: failure to use nonverbal behaviors to
regulate social interaction, and VABS-social ability
(Table 3). Furthermore, rs7294536 was weakly associated
with quantitative traits (p = 0.02–0.045). Weak associa-
tions were observed between the social phenotypes and
either microsatellite polymorphisms. In the recessive
model under the bi-allelic mode, the RS3–328 allele only
showed weak significance with quantitative social pheno-
type scores (p = 0.02–0.036) (Additional file 1: Table S3
shows this in more detail).
Haplotype analyses of the quantitative traits for the
RS1/SNP and SNP/SNP combinations were statistical
significant. A significant effect was observed between
the A/A and A/G haplotypes of rs7294536/rs10877969
for quantitative traits related to sociality in all models
and modes (p < 0.05). The haplotype rs7294536/RS1/
rs10877969 (A/310/A) and social traits were significantly
associated in the additive model under multi-allelic
mode (p < 0.001). Results for the A/G haplotype of
rs7294536/rs10877969 was also significantly associated
with social traits (p = 0.001–0.025).
A multi-trait test was performed for multiple traits
(SCQ, ASDS, SRS, K-CBCL social problems, and VABS in
bi-allelic mode and multi-allelic mode) and the rs7294536
and rs10877969 SNPs. The results from all models under
the bi-allelic mode were statistically significant (additive
model, p = 0.009; dominant model, p = 0.015; and
recessive model, p = 0.015) (Additional file 1: Table S4
shows this in more detail). In the recessive model analysis
for the A allele, variations of ADI-A4 measured between
the AG/GG allele and AA allele had statistical significant
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Table 1 Family-based association test of polymorphisms in AVPR1A promoter region
Marker Bi-allelic mode Model Additive Dominant Recessive
Allele Freq. N Z p N Z p N Z p
RS3 326 0.062 38 − 0.617 0.537 37 − 0.714 0.475 – – –
328 0.207 96 0.183 0.855 94 − 0.464 0.643 21 0.612 0.107
330 0.255 104 − 0.254 0.799 95 − 0.981 0.327 37 1.172 0.241
332 0.202 97 1.044 0.296 91 1.272 0.203 18 − 0.25 0.803
334 0.186 98 0.447 0.655 94 − 0.621 0.535 25 0.221 0.825
rs7294536 A 0.807 112 2.062 0.039 36 2.043 0.041 36 − 2.043 0.041
G 0.193 112 − 2.062 0.039 107 − 1.386 0.166 – – –
RS1 306 0.087 59 0.367 0.714 58 0.131 0.896 107 1.386 0.166
310 0.414 152 1.490 0.136 122 2.302 0.021 86 − 0.288 0.773
314 0.221 124 − 1.121 0.262 119 − 0.323 0.747 31 − 2.090 0.037
318 0.083 62 − 1.543 0.123 61 − 1.440 0.150 – – –
322 0.057 39 0.000 1.000 39 0.155 0.877 – – –
326 0.130 77 0.211 0.833 76 0.349 0.727 13 − 0.316 0.752
rs10877969 A 0.911 68 4.796 0.001 18 2.177 0.030 67 4.573 < 0.001
G 0.089 68 − 4.796 0.001 67 − 4.573 < 0.001 18 − 2.177 0.030
Multi-allelic mode Df χ2 p Df χ2 p Df χ2 p
RS3 5 1.598 0.902 5 4.436 0.489 4 4.133 0.388
rs7294536 1 4.525 0.039 2 5.377 0.068 2 5.377 0.068
RS1 6 4.517 0.607 6 8.425 0.209 3 4.634 0.201
rs10877969 1 23.000 < 0.001 2 23.206 < 0.001 2 23.206 < 0.001
Allele over-transmitted allele, Freq. frequency, N number of informative nuclear families, Z Z score from family-based association test, Df degree of freedom, χ2 χ2
statistics, p, p value
Table 2 Haplotype analysis of polymorphisms in promoter region of AVPR1A
Marker Biallelic mode Model Additive Dominant Recessive
Haplotype Freq. N Z p N Z p N Z p
1-3 330-310 0.135 70 − 0.753 0.452 69 − 0.770 0.441 11 − 0.164 0.869
2-4 A-A 0.736 133 3.826 < 0.001 55 3.651 < 0.001 118 2.655 0.001
A-G 0.064 48 − 3.586 < 0.001 48 − 3.311 < 0.001 – – –
1-2 330-A 0.235 109 − 0.230 0.818 99 − 0.937 0.349 33 1.212 0.225
2-3 A-310 0.384 145 1.639 0.101 116 2.112 0.035 72 0.125 0.900
3-4 310-A 0.367 149 2.552 0.011 124 2.995 0.003 72 0.564 0.573
1-2-3 330-A-310 0.125 65 − 0.891 0.373 65 − 1.045 0.296 10 0.174 0.862
2-3-4 A-310-A 0.352 142 2.505 0.012 118 2.650 0.008 61 0.878 0.380
Multi-allelic mode Df χ2 p Df χ2 p Df χ2 p
1-3 6 6.538 0.366 6 5.425 0.491 – – –
2-4 3 24.302 < 0.001 3 20.364 < 0.001 2 9.650 0.008
1-2 6 3.859 0.696 6 3.779 0.707 3 6.899 0.075
2-3 5 5.594 0.348 5 7.474 0.188 2 2.148 0.341
3-4 5 18.501 0.002 5 18.934 0.002 2 4.027 0.134
1-2-3 6 7.455 0.281 6 6.676 0.352 – – –
2-3-4 5 19.869 0.001 5 17.603 0.003 2 2.612 0.271
1 RS3 (complex), 2 rs7294536, 3 RS1 (GATA), 4 rs10877969, N number of informative nuclear families, Df degree of freedom, χ2 χ2 statistics, p p value
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differences (t = 2.434; p = 0.016) (Additional file 1:
Table S5 shows this in more detail).
Luciferase assay
The relative luciferase activity for the promoter with
the rs7294536 A allele was significantly higher than
that of the G allele. However, rs10877969 allelic vari-
ants did not influence promoter activity (Fig. 1a).
Analyses of transcriptional factor binding site
To investigate whether the putative Nf-κB involvement
is due to a transcriptional event in the AVPR1A pro-
moter region, we synthesized 22-mer oligonucleotide
probes with adjacent sequences of rs7294536 and then
performed an EMSA with radiolabeled DNA. From the
luciferase assays, the promoter activities of each con-
struct were measured under normal conditions without
the activation of any pathways. Therefore, first, EMSA
Table 3 Family-based association results of polymorphisms in AVPR1A with single quantitative trait by additive model
Traits SCQ ASDS SRS K-CBCL ADIR-A1 ADIR-A2 ADIR-A3 ADIR-A4 ADIR-total VABS
Marker Freq. N p p p p p p p p p p
rs7294536 G 0.193 71 0.049 0.019 0.033 0.015 0.016 0.029 0.030 0.019 0.021 0.407
rs7294536 A 0.807 71 0.049 0.019 0.033 0.015 0.016 0.029 0.030 0.019 0.021 0.407
rs10877969 G 0.089 47 0.001 < 0.001 < 0.001 < 0.001 0.001 0.001 0.001 0.002 0.001 < 0.001
rs10877969 A 0.911 47 0.001 < 0.001 < 0.001 < 0.001 0.001 0.001 0.001 0.002 0.001 < 0.001
Freq. allele frequency, N number of informative nuclear families, p p value, SCQ Social Communication Questionnaires, ASDS Asperger Syndrome Diagnostic Scale,
SRS social responsiveness scale, K-CBCL Korean Child behavior checklist (social problems), K-ADIR Autism Diagnostic Interview-Revised, ADI-A1 failure to use
nonverbal behaviors to regulate social interaction, ADI-A2 failure to develop peer relationship, ADI-A3 lack of shared enjoyment, ADI-A4 lack of socioemotional
reciprocity, VABS Vineland Adaptive Behavior Scales
Fig. 1 Luciferase assays and electrophoresis mobility-shift assay (EMSA). a Luciferase assays with vector constructs which were contained poly-
morphic sites, rs7294536 (−1502 A/G) and rs10877969 (− 649 A/G) in promoter region of the AVPR1A. The RLU values were denoted by mean and
error bars by ± SD (n = 6). ***p < 0.001, **p < 0.01. b EMSA with oligonucleotides containing the rs7294536A or rs7294536G allele, c Western blot-
ting with nuclear extract of T98G induced by 30 ng/ml of TNF-α. d Supershift assays with p65 and p50 antibodies and nuclear extract induced by
30 ng/ml TNF-α for 15 min
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was performed with the nuclear extracts of 1, 3, 5, 10,
and 20 μg in un-induced conditions for the Nf-κB
pathway. We observed that the probe containing the
rs7294536 G allele had a stronger binding affinity to
unknown and nonspecific proteins than the A allele. To
induce the Nf-κB pathway, the cells were treated with
TNF-α (30 ng/ml) for 0, 15, 30, or 180 min. The nuclear
extracts of the cells that were stimulated for 30 min
showed the strongest band intensity. Thereafter, the nu-
clear proteins from this time point were used. Stimulating
the cells with TNF-α resulted in a significant time-
dependent increase in binding between the nuclear
proteins and the probe when compared with the unstimu-
lated cells. The binding of nuclear proteins to probes for
the rs7294536 A and G alleles were discriminatively de-
tected by EMSA. A higher intensity band was observed
for the probe containing the rs7294536 A allele than the
rs7294536 G allele (Fig. 1b). To verify the quantity of
nuclear proteins used in the EMSA, we performed a
western blot analysis for p50 and p65, and SP-1 was used
as an internal control. The levels of p65 and p50 in the
nuclear extract of the cells stimulated with TNF-α for 15
and 30 min were increased when compared to the un-
stimulated cells, and SP-1 was detected uniformly (Fig. 1c).
To confirm the specificity for the binding of nuclear pro-
teins to each probe, a competition experiment was per-
formed by mixing the nuclear proteins with anti-p50 and
anti-p65 antibodies before treating them with the labeled
probes. We observed supershifted bands for p65 and p50 in
the competition assay (Fig. 1d). Overall, this study suggests
that the rs7294536 A/G polymorphisms affect the Nf-κB
binding site affinity. Furthermore, these results demonstrate
that SNPs in the promoter region of AVPR1A are indeed in-
volved in regulating the expression of the AVPR1A.
Discussion
Though comparisons between AVPR1A microsatellites
and social behaviors have been previously reported in ani-
mal models, the associations of specific markers with ASD
have not yet been replicated. Results from a previous asso-
ciation study between families with ASD and RS1 and RS3
in AVPR1A have been inconsistent with our previous
study [23] as well as others’ studies. Kim et al. [15] first
found nominally significant transmission disequilibrium of
332 bp in RS3 in 115 non-ethnic-matched ASD families
but not by a low power in Bonferroni correction. Next,
Wassink et al. [16] replicated an association test between
the RS1 and RS3 microsatellites in Caucasian families with
autism and found a strong transmission disequilibrium for
328 bp in RS3 and RS1-(GATA)9 in the “normal language”
subgroup families. Yirmiya et al. [17], who studied 114
Israeli families, found a significant association with
moderate LD between ASD and new markers located in
the intron of AVPR1A.
The differences between these studies in regard to
preferentially transmitted alleles may be due to the dif-
ferent ethnic groups that were studied and the varied
statistical methodologies or sample size. In this study,
our failure to replicate the genetic associations between
microsatellite markers in AVPR1A and Korean individ-
uals with ASD from our original study could be due to a
several reasons. Firstly, our original findings might be
false positives from lack of replication. Next, it can be
possible that there is lack of adequate power to detect or
replicate an association result because of lack of
adequate sample size for the analysis of multiple alleles.
We also cannot rule out the possibility that microsatel-
lites frequently inherited by de novo alterations can also
affect susceptibility [34]. Moreover, clinical heterogeneity
of ASD must be considerable factor for replication
failure.
Previously, we have suggested that microsatellites and
SNPs of AVPR1A might be genetically involved in ASD
[23, 24]. Moreover, this study also suggested that the
social trait values among families with ASD were signifi-
cantly associated with their genotypes. To the best of
our knowledge, there has been no other replication
study for AVPR1A polymorphisms in independent
cohorts within the same population. This family-based
association study replicated the results that suggested
rs7294536 G and rs10877939 G alleles of AVPR1A have
been over-transmitted as risk allele in families with ASD.
A significantly low p value for rs10877939 and a moder-
ate p value for rs7294536 in the FBAT were observed.
These results are consistent with previous reports with
other ethnicities. Tansey et al. [13] showed an associ-
ation between autism and the SNPs in the AVPR1A pro-
moter, demonstrating a single association with AVPR1A
in an Irish autism trio collection with a corrected p value
of 0.01 for rs11174815, a tag SNP located 143 bp down-
stream from rs10877969. However, this group concluded
that a lack of a relationship between this marker and
autism in the Irish autism sample population was prob-
ably due to the very low minor allele frequency
(MAF = 0.015).
In the pathogenesis of ASD, it is assumed that multiple
gene variants may be involved, each making small quanti-
tative contributions to the final phenotype [35]. Reciprocal
social interaction is one of the representative final pheno-
types of ASD that is affected by genetic variants. In this
study, two SNPs in AVPR1A showed significant quantita-
tive associations with multiple measures of social behav-
iors and reciprocity both in current (ASDS, SRS, and
VABS) and past developmental periods (ADI-R and SCQ),
similar to that reported by Yirmiya et al. [17]. It also sup-
ports the notion that polymorphisms in the promoter re-
gion of AVPR1A might contribute to the dysregulation of
social behavior, rather than the development of ASD itself,
Yang et al. Molecular Autism  (2017) 8:44 Page 7 of 10
though studies in this area has been largely inconsistent
between studies [36–39].
In addition, the functional role of the RS1 and RS3
microsatellites in AVPR1A has also been previously dem-
onstrated by luciferase assays [13]. The shorter alleles of
RS1 were hypothesized to increased susceptibility to aut-
ism as a result of decreased AVPR1A expression.
However, compared to microsatellites, few studies have
studied the function of SNPs in this region. Here, we in-
vestigated the potential role of the rs7294536 and
rs10877969 SNPs in the promoter region by examining
their effect on relative promoter activity and transcrip-
tional factor interactions. We focused on rs7294536
since it is located in the recognition sequences for the
Nf-κB transcription factors, which is expected to bind
with p65. The construct with the rs7294536 A allele
showed higher relative promoter activity, especially
when Nf-κB pathway was overexpressed. Through the
EMSA, it was confirmed that the Nf-κB binding affinities
varied according to the rs7294536 alleles.
In our previous study, the rs7294536 A allele was
over-transmitted in families with ASD and was consid-
ered a risk allele for ASD [24]. However, the rs7294536
A allele was observed to have higher relative promoter
activity, which was counter to our hypothesis that lower
promoter activity was related to autism-related deficits
of behavior [12, 13]. This may be due varying AVPR1A
expression levels and transfection efficiencies in the
T98G cells used in this study. The T98G cell line is non-
neuronal since it originated from human glioblastoma
multiforme. Therefore, this can result in experimental
inconsistencies with our previous study where the SH-
SY5Y cell line was used instead.
Secondly, our experimental setup for the promoter
activity study is reminiscent of inflammatory situations
[40, 41]. The expression of IL-1β, IL-6, IL-17, and TNF in-
flammatory molecules is increased in the brain, cerebro-
spinal fluid, and serum of some patients with ASD,
whereas NF-kB is activated in the brain, which then stim-
ulates peripheral blood immune cells in patients with
autism [42–44]. Nf-κB has been recognized as a member
of the Rel transcription factor family and the most widely
studied form of NF-κB is a heterodimer of the p50 and
p65 subunits, which functions as a potent activator of
gene transcription [40]. Moreover, neurons, astrocytes,
and microglia from patients with ASD revealed higher ex-
pression of the p65 subunit of NF-κB as compared with
matched controls. Therefore, NF-κB signaling was prom-
inent in the interacting gene networks that were con-
structed from the brains of patients with ASD [45]. We
hypothesized that elevated NF-κB might result in the pro-
tection of neuronal connectivity and signaling network
due to the elevated AVPR1A expression. In this study, in-
creased differences in the relative promoter activities of
the rs7294536 A and rs7294536 G alleles were observed
when cells overexpressed Nf-κB or treated with TNF-α as
compared with untreated condition. This was also ob-
served via EMSA by the differences in binding affinities
between the rs7294536 A and rs7294536 G alleles.
This study could provide novel insight into the
transcriptional regulation of AVPR1A and the poten-
tial biological roles of its gene product. Therefore, the
role of AVPR1A polymorphisms should be explored
with regard to the neurobiology of ASD, especially in
the context of NF-κB signaling pathway. To investi-
gate its molecular biological aspects, the expression
pattern for the rs7294536 A/G alleles in AVPR1A in
several cell types and specific brain regions of differ-
ent organisms will be required. Furthermore, AVPR1A
expression in the brain, the related polymorphic
alleles, and subsequent activation of NF-κB signaling
during inflammation will be needed to corroborate
this study.
Although single predictable genetic markers were
uninformative, multiple reports with accumulating
evidence have demonstrated genetic associations with
ASD [46]. Moreover, the carefully selected sets of critical
genes should be able to be applied to sub-groups of ASD
as classified by age, sex, severity, and phenotypic traits
[47]. Overall, we identified a functional polymorphic site
in AVPR1A that may be possibly important for
socialization in ASD, and evidence was provided for its
mechanistic biological role in the present study. The
limitations of this study are; first, we only assessed two
polymorphisms that were frequently observed in patients
with ASD in this study. However, it is also possible that
other undetected polymorphisms may have overt func-
tion with rs7294536 in the LD region, as there may be
high LD with variants not tested. Second, the reason for
inconsistency in the association analyses in microsatellite
polymorphisms between current study and our previous
report are not fully explained. Lastly, as the behavioral
characteristics of the parents are not evaluated, there
was limitation in examining relationship between
AVPR1A variants and behavioral functioning in the con-
text of broader autism phenotype.
Conclusion
In this family-based association study, we validated our pre-
vious study between ASD and the polymorphisms in
AVPR1A with independent samples. Also, we observed
quantitative correlation between genotypes and quantitative
traits in probands with ASD. Luciferase and electrophoretic
mobility-shift assays exhibited differential binding affinities
depending on the allele of associated SNP. These results
demonstrate that polymorphisms in the AVPR1A promoter
region might be involved in pathophysiology of ASD and in
functional regulation of the expression of AVPR1A.
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